GlobeNewswire by notified

Savosolar Plc publishes a company description due to the acquisition of Meriaura Oy

Share

Savosolar Plc
Company Announcement                            18 November 2022 at 1.30 p.m. (CET)

Savosolar Plc publishes a company description due to the acquisition of Meriaura Oy

Due to the acquisition of Meriaura Oy, Savosolar Plc publishes a company description that has been reviewed and approved by Nasdaq Stockholm AB. The company description is available on Savosolar Plc’s website (www.savosolar.com).

The company description concerns the share exchange through which Savosolar Plc plans to acquire all the shares in Meriaura Oy and its fully owned subsidiary Biolaite Oy (name change to VG-EcoFuel Oy pending).

SAVOSOLAR PLC

For more information:
Savosolar Plc
Managing Director Jari Varjotie
Phone: +358 400 419 734
E-mail: jari.varjotie@savosolar.com


About Savosolar
Savosolar with its highly efficient collectors and large-scale solar thermal systems has taken solar thermal technology to the next level. The company’s collectors are equipped with the patented nano-coated direct flow absorbers, and with this leading technology, Savosolar helps its customers to produce competitive clean energy. Savosolar’s vision is to be the first-choice supplier to high performance solar installations on a global scale. Focus is on large-scale applications like district heating, industrial process heating and real estate systems – market segments with a big potential for rapid growth. The company primarily delivers complete systems from design to installation, using the best local partners. Savosolar is known as the most innovative company in the business and aims to stay as such. The company has sold and delivered its products to almost 20 countries on four continents. Savosolar’s shares are listed on Nasdaq First North Growth Market Sweden with the ticker SAVOS and on Nasdaq First North Growth Market Finland with the ticker SAVOH. www.savosolar.com.

The company’s Certified Adviser is Augment Partners AB, info@augment.se, phone: +46 8-604 22 55.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

ABG Sundal Collier Initiates Coverage of CoinShares International Limited8.5.2024 15:21:20 CEST | Press release

8th May 2024 | SAINT HELIER, Jersey | CoinShares International Limited (“CoinShares'' or “the Group”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF), the leading European investment company specialising in digital assets, is pleased to announce that ABG Sundal Collier has initiated coverage of the Company. Click here to view the full report or here to download the report. ABOUT COINSHARES CoinShares is the leading European investment company specialising in digital assets, that delivers a broad range of financial services across investment management, trading and securities to a wide array of clients that includes corporations, financial institutions and individuals. Focusing on crypto since 2013, the firm is headquartered in Jersey, with offices in France, Sweden, Switzerland, the UK and the US. CoinShares is regulated in Jersey by the Jersey Financial Services Commission, in France by the Autorité des marchés financiers, and in the US by the Financial Industry Regulatory Authority. CoinShar

Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S8.5.2024 15:16:55 CEST | Press release

8 May 2024 Announcement No. 16 Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S In continuation of company announcement no. 15 of 8 May 2024 regarding notice of an extraordinary general meeting, to be held on 3 June 2024. with a view to reducing the company's capital, the Board of Directors of Pharma Equity Group A/S ("PEG") has today decided to explore the possibilities of strengthening PEG's working capital through a capital increase at market price. Any directed capital increase will be expected to be carried out without a prospectus being prepared due to the expected size of the capital increase. Any capital increase will be subject to the adoption of the capital reduction. The specific details of a possible capital increase will be published when and if the Board of Directors decides to do so. For further information, please contact: Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: +45 4022 2114 Christian Vinding Thom

Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S8.5.2024 15:16:55 CEST | pressemeddelelse

8. maj 2024 Meddelelse nr. 16 Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S I forlængelse af selskabsmeddelelse nr. 15 fra 8. maj 2024 angående indkaldelse til en ekstraordinær generalforsamling den 3. juni 2024 med henblik på at nedsætte selskabets kapital, har bestyrelsen i Pharma Equity Group A/S ("PEG") i dag truffet beslutning om at afsøge mulighederne for at styrke PEG's arbejdskapital ved en kapitalforhøjelse til markedspris. En eventuel rettet kapitalforhøjelse vil forventeligt blive gennemført uden, at der udarbejdes et prospekt grundet kapitalforhøjelses forventede størrelse. En eventuel kapitalforhøjelse vil forudsætte, at kapitalnedsættelsen vedtages. De konkrete detaljer omkring en eventuel kapitalforhøjelse vil blive offentliggjort når og hvis bestyrelsen måtte træffe beslutning herom. For yderligere information, kontakt venligst: Thomas Kaas Selsø, adm. direktør i Pharma Equity Group A/S, telefon: +45 4022 2114 Chr

Standard Lithium and Equinor Form Partnership to Develop South West Arkansas and East Texas Lithium Projects8.5.2024 14:00:00 CEST | Press release

Equinor Commits to Contribute up to a US$160 million Gross Investment for a 45% interest in two special purpose entities with SLI to develop a sustainable lithium business in the United States VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today announced the closing of a landmark strategic partnership (the “Transaction”) with Equinor ASA (NYSE: EQNR), a multinational energy company and recognized leader in renewables and low-carbon solutions, to accelerate the development of Standard Lithium’s large-scale, sustainable lithium projects in the Smackover Formation. The Transaction includes Equinor's contribution of up to US$160 million, representing its total gross project-level investment and reflecting its 45% ownership stake in the two entities. This investment includes a US$30 million cash payment to Standard Lithi

HiddenA line styled icon from Orion Icon Library.Eye